Zura Bio Limited said it has appointed Sandeep Kulkarni as chief executive, effective Wednesday. The clinical-stage biotechnology company said Kulkarni will continue serving as a director. Kulkarni ...

HENDERSON, Nev., January 21, 2026--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) ("Zura" or the "Company"), a clinical-stage biotechnology company developing novel and differentiated medicines to ...

Shares of Zura Bio climbed after the company appointed Sandeep Kulkarni as its chief executive. Shares were up 12% to $5.60 on Wednesday afternoon after hitting a 52-week high of $5.87 earlier in the ...

HENDERSON, Nev. - Clinical-stage biotechnology company Zura Bio Limited (NASDAQ:ZURA) has appointed Sandeep Kulkarni as Chief Executive Officer, effective January 21, 2026, according to a company ...

There is a growing body of evidence on the role of inflammation in predicting heart health. In a new pharmaphorum podcast to kick off December - in which month we'll be bringing you an episode a day ...

Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with ...

Dr. Kulkarni brings over two decades of experience across biotechnology, investment, entrepreneurship, and medicine. Most recently, he served as co-founder and CEO of Tourmaline Bio, where he guided ...